Skip to main content
. 2014 Jan 21;20(3):814–821. doi: 10.3748/wjg.v20.i3.814

Table 5.

Type of treatment, relapses, histopathological and laboratory findings of ulcerative colitis patients

Treatment used: (single drug or combinations) Oral 5-ASA ±, 5-ASAenemas or supp., prednisone, azathioprine, corticosteroids enemas. (Infliximab was used in 2 cases)
Surgical interference (yes/no) 4/131
Relapses (mean ± SD) 1.514 ± 1.575
Relapses (median/minimum/maximum) 1/0/10
Malignant transformation 1
Mean ESR 1st hour (mean ± SD) 36.37 ± 24.73
CRP (positive/negative/not done) 39/34/60
ANCA (positive/negative/not done) 12/28/95
ASCA (positive/negative/not done) 8/31/96
Pathological findings included: Vascular congestion, Crypt abscesses, Mucin depletion, Cellular infiltrate, Cryptitis, Crypt branching
Pathology (diagnostic/suggestive/non conclusive) 78/43/14
Mean Hemoglobin concentration, gm/dL (mean ± SD) 11.2 ± 2.8
Mean PLT count (mean ± SD) 335428.6 ± 140119.1
Mean TLC (mean ± SD) 8875 ± 4059.67

ASA: Aminosalicylic acid; CRP: C-reactive protein; ANCA: Anti-neutrophil cytoplasmic antibodies; ASCA: Anti-Saccharomyces cerevisiae antibodies.